Mariluz Rodriguez-Gonzalez

This inventor holds 3 USPTO granted patents. Top assignee: University of Massachusetts. Active years: 2015-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mariluz Rodriguez-Gonzalez. Retrieved from https://idiyas.com/inventor/mariluz-rodriguez-gonzalez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 3

% Patents Active = 66.7

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)

Company Filing History:

3 out of 1,633

University of Massachusetts

patents

Years Active: 2015-2019

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10227591 - Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (miR145) and micro-RNA 212 (miR212) (2019-03-12),

2. 9562232 - Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (miR145) and micro-RNA 212 (miR212) (2017-02-07),

3. 8933045 - Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (mi145) and micro-RNA 212 (miR212) (2015-01-13),

Title: Innovations of Mariluz Rodriguez-Gonzalez

Introduction

Mariluz Rodriguez-Gonzalez is a prominent inventor based in Worcester, MA (US). She has made significant contributions to the field of molecular biology, particularly in the modulation of human cytomegalovirus (HCMV) replication. With a total of three patents to her name, her work has implications for both research and therapeutic applications.

Latest Patents

Rodriguez-Gonzalez's latest patents focus on the modulation of HCMV replication by specific micro-RNAs, namely miR132, miR145, and miR212. The inventions detail how miR145 is downregulated in cells infected with HCMV, affecting the expression of target genes such as IRS-1. By transfecting cells with a miR145 agent, such as a mimetic, HCMV replication and protein expression can be reduced. Conversely, miR132 and miR212 are upregulated in HCMV-infected cells, influencing the expression of target genes like MeCP2 and RICS. The patents provide methods for attenuating HCMV replication through the modulation of these micro-RNAs and offer compositions and kits for detecting HCMV infections.

Career Highlights

Rodriguez-Gonzalez is affiliated with the University of Massachusetts, where she conducts her research. Her innovative work has positioned her as a key figure in the study of viral infections and their molecular mechanisms.

Collaborations

Some of her notable collaborators include Timothy F Kowalik and Alexander Lagadinos, who have contributed to her research endeavors.

Conclusion

Mariluz Rodriguez-Gonzalez's contributions to the understanding of HCMV replication through micro-RNAs highlight her role as an influential inventor in the field of molecular biology. Her patents not only advance scientific knowledge but also pave the way for potential therapeutic strategies against viral infections.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]